These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19112768)

  • 1. Etanercept in therapy multiresistant overlapping pityriasis lichenoides.
    Nikkels AF; Gillard P; Piérard GE
    J Drugs Dermatol; 2008 Oct; 7(10):990-2. PubMed ID: 19112768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyoderma vegetans associated with severe psoriatic arthritis: good response to etanercept.
    Carrera C; Mascaró JM; Moreno-Romero JA; Iranzo P; Palou J; Zamora E; Herrero C
    Dermatology; 2007; 214(1):77-81. PubMed ID: 17191052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parapharyngeal abscess in a patient receiving etanercept.
    Borrás-Blasco J; Nuñez-Cornejo C; Gracia-Perez A; Rosique-Robles JD; Casterá MD; Viosca E; Abad FJ
    Ann Pharmacother; 2007 Feb; 41(2):341-4. PubMed ID: 17227824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical experience with etanercept in the treatment of psoriasis].
    Martín B; Sánchez-Carazo JL; Pérez-Ferriols A; Laguna C; Oliver V; Alegre V
    Actas Dermosifiliogr; 2008 Sep; 99(7):540-5. PubMed ID: 18682167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subacute annular generalized pustular psoriasis treated with etanercept and cyclosporine combination.
    Ricotti C; Kerdel FA
    J Drugs Dermatol; 2007 Jul; 6(7):738-40. PubMed ID: 17763600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transition of pityriasis lichenoides et varioliformis acuta to febrile ulceronecrotic Mucha-Habermann disease is associated with elevated serum tumour necrosis factor-alpha.
    Tsianakas A; Hoeger PH
    Br J Dermatol; 2005 Apr; 152(4):794-9. PubMed ID: 15840118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recalcitrant cicatricial pemphigoid treated with the anti-TNF-alpha agent etanercept.
    Kennedy JS; Devillez RL; Henning JS
    J Drugs Dermatol; 2010 Jan; 9(1):68-70. PubMed ID: 20120429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the tolerability and efficacy of etanercept compared to triamcinolone acetonide for the intralesional treatment of keloids.
    Berman B; Patel JK; Perez OA; Viera MH; Amini S; Block S; Zell D; Tadicherla S; Villa A; Ramirez C; De Araujo T
    J Drugs Dermatol; 2008 Aug; 7(8):757-61. PubMed ID: 18720692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of calcipotriol on etanercept partial responder psoriasis vulgaris and psoriatic arthritis patients.
    Campione E; Mazzotta A; Paternò EJ; Diluvio L; Prinz JC; Chimenti S
    Acta Derm Venereol; 2009; 89(3):288-91. PubMed ID: 19479128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary sarcoidosis associated with etanercept therapy.
    Farah RE; Shay MD
    Pharmacotherapy; 2007 Oct; 27(10):1446-8. PubMed ID: 17896899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of pemphigus vulgaris with etanercept in four patients.
    Shetty A; Marcum CB; Glass LF; Carter JD
    J Drugs Dermatol; 2009 Oct; 8(10):940-3. PubMed ID: 19852124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of bromelain in the treatment of patients with pityriasis lichenoides chronica.
    Massimiliano R; Pietro R; Paolo S; Sara P; Michele F
    J Dermatolog Treat; 2007; 18(4):219-22. PubMed ID: 17671882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful etanercept therapy in therapy refractory acrodermatitis continua suppurativa Hallopeau.
    Weisshaar E; Diepgen TL
    J Dtsch Dermatol Ges; 2007 Jun; 5(6):489-92. PubMed ID: 17537042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of etanercept as a non-surgical treatment for temporomandibular joint psoriatric arthritis: a case report.
    Lamazza L; Guerra F; Pezza M; Messina AM; Galluccio A; Spink M; De Biase A
    Aust Dent J; 2009 Jun; 54(2):161-5. PubMed ID: 19473159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTACK /CCL27 expression in psoriatic skin and its modification after administration of etanercept.
    Campanati A; Goteri G; Simonetti O; Ganzetti G; Giuliodori K; Stramazzotti D; Morichetti D; Bernardini ML; Mannello B; Fabris G; Offidani A
    Br J Dermatol; 2007 Dec; 157(6):1155-60. PubMed ID: 17916208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up of psoriatic arthritis mutilans patients treated with anti-TNF-alpha therapy.
    Pomerantz RG; Mody E; Husni ME; Qureshi AA
    J Drugs Dermatol; 2009 Apr; 8(4):406-12. PubMed ID: 19363860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pityriasis lichenoides chronica.
    Henning JS
    Dermatol Online J; 2004 Nov; 10(3):8. PubMed ID: 15748578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic hotline. Treatment of pityriasis rubra pilaris with etanercept.
    Guedes R; Leite L
    Dermatol Ther; 2011; 24(2):285-6. PubMed ID: 21410618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the therapeutic effects of narrow band UVB vs. PUVA in patients with pityriasis lichenoides.
    Farnaghi F; Seirafi H; Ehsani AH; Agdari ME; Noormohammadpour P
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):913-6. PubMed ID: 21054568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.